When the baby is in the NICU, who's caring for the mom? A new model is changing that
When a newborn lands in the NICU, all eyes turn to the tiniest patient in the room. But what happens to the person still recovering from labor and delivery—especially if they're battling physical complications or mental health challenges while sitting beside an incubator?
Dr. Heather Burris, a neonatologist and senior fellow at the University of Pennsylvania's Leonard Davis Institute of Health Economics (LDI), noticed a disturbing pattern. 'In my job, I encounter parents choosing to stay with their babies in the NICU instead of seeking their own health care,' she said. Even when a mother has a potentially serious condition like postpartum hypertension or a surgical site infection, 'they must leave their baby's bedside and go to the closest emergency room, requiring separation from their baby to get care.'
It's a gap in postpartum care that's hiding in plain sight.
Related: 5 reasons why NICU parents might be more susceptible to depression and anxiety
My daughter was born six weeks early and spent 10 days in the NICU. Even though her condition was stable, that stretch of time remains one of the most harrowing experiences of my life. There is nothing that can prepare you for seeing your tiny baby hooked up to machines helping them breathe—a vivid reminder of how fragile new life can be.
In the days that followed her birth, I was battling more than exhaustion. I experienced symptoms of postpartum PTSD, but no one seemed to notice—not my loved ones, and not my medical team. I kept showing up at her bedside, putting on a brave face, even as I felt myself unraveling inside. Looking back, I wish one of the nurses or doctors had asked how I was doing, not just how she was. It might have saved me months of silent suffering.
Related: When my youngest daughter was in the NICU, I felt like I was failing both of my kids
A new randomized controlled trial, published in American Journal of Obstetrics & Gynecology Maternal-Fetal Medicine on May 5, 2025, is reimagining how care is delivered to these parents—by embedding it right where they are. The Postpartum Care in the Neonatal Intensive Care Unit (PeliCaN) model brings doulas and nurse-midwives directly into the NICU, helping mothers access the care they urgently need without leaving their baby's side.
'Several of our control participants never had their blood pressure checked after they left the hospital after giving birth, even though they had telehealth visits,' Burris noted. In contrast, the 20 parents who received the PeliCaN intervention got care a median of 20 days earlier than the control group. They were also far less likely to miss vital components of postpartum care, like blood pressure checks.
The doulas—deployed within the first week postpartum—offered both emotional and physical support. 'Doulas interact with mothers at least once in person, and follow up via phone, text, and video chat,' Burris explained. 'They help mothers overcome barriers to postpartum care.'
That support made a meaningful difference. While nearly all study participants eventually received some form of postpartum care, Burris emphasized, '30% of controls were missing a core component of postpartum care, most often blood pressure measurements in the setting of telehealth visits.'
Related: 5 ways I became a better labor & delivery nurse by being a NICU mama
And in some cases, the intervention may have been life-saving. 'We found severe hypertension even in mothers who hadn't had hypertension before. Other mothers shared suicidal ideation requiring immediate intervention. I truly believe that doulas can be lifesaving.'
What's next for maternal care innovationScaling this model will take time, training, and policy support—but Burris and her team are hopeful. Integrating maternal care into NICUs isn't just about convenience; it's about survival, dignity, and supporting mothers as whole people, not just caregivers.
'Her baby was in the NICU—but no one was checking on her.' That may soon change.
Sources:
LDI Blog Post: 'Parents of Hospitalized Infants Often Neglect Their Own Health Care'
American Journal of Obstetrics & Gynecology Maternal-Fetal Medicine, May 2025 Publication
Direct quotes from Dr. Heather Burris via LDI interview, June 4, 2025
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
When the baby is in the NICU, who's caring for the mom? A new model is changing that
When a newborn lands in the NICU, all eyes turn to the tiniest patient in the room. But what happens to the person still recovering from labor and delivery—especially if they're battling physical complications or mental health challenges while sitting beside an incubator? Dr. Heather Burris, a neonatologist and senior fellow at the University of Pennsylvania's Leonard Davis Institute of Health Economics (LDI), noticed a disturbing pattern. 'In my job, I encounter parents choosing to stay with their babies in the NICU instead of seeking their own health care,' she said. Even when a mother has a potentially serious condition like postpartum hypertension or a surgical site infection, 'they must leave their baby's bedside and go to the closest emergency room, requiring separation from their baby to get care.' It's a gap in postpartum care that's hiding in plain sight. Related: 5 reasons why NICU parents might be more susceptible to depression and anxiety My daughter was born six weeks early and spent 10 days in the NICU. Even though her condition was stable, that stretch of time remains one of the most harrowing experiences of my life. There is nothing that can prepare you for seeing your tiny baby hooked up to machines helping them breathe—a vivid reminder of how fragile new life can be. In the days that followed her birth, I was battling more than exhaustion. I experienced symptoms of postpartum PTSD, but no one seemed to notice—not my loved ones, and not my medical team. I kept showing up at her bedside, putting on a brave face, even as I felt myself unraveling inside. Looking back, I wish one of the nurses or doctors had asked how I was doing, not just how she was. It might have saved me months of silent suffering. Related: When my youngest daughter was in the NICU, I felt like I was failing both of my kids A new randomized controlled trial, published in American Journal of Obstetrics & Gynecology Maternal-Fetal Medicine on May 5, 2025, is reimagining how care is delivered to these parents—by embedding it right where they are. The Postpartum Care in the Neonatal Intensive Care Unit (PeliCaN) model brings doulas and nurse-midwives directly into the NICU, helping mothers access the care they urgently need without leaving their baby's side. 'Several of our control participants never had their blood pressure checked after they left the hospital after giving birth, even though they had telehealth visits,' Burris noted. In contrast, the 20 parents who received the PeliCaN intervention got care a median of 20 days earlier than the control group. They were also far less likely to miss vital components of postpartum care, like blood pressure checks. The doulas—deployed within the first week postpartum—offered both emotional and physical support. 'Doulas interact with mothers at least once in person, and follow up via phone, text, and video chat,' Burris explained. 'They help mothers overcome barriers to postpartum care.' That support made a meaningful difference. While nearly all study participants eventually received some form of postpartum care, Burris emphasized, '30% of controls were missing a core component of postpartum care, most often blood pressure measurements in the setting of telehealth visits.' Related: 5 ways I became a better labor & delivery nurse by being a NICU mama And in some cases, the intervention may have been life-saving. 'We found severe hypertension even in mothers who hadn't had hypertension before. Other mothers shared suicidal ideation requiring immediate intervention. I truly believe that doulas can be lifesaving.' What's next for maternal care innovationScaling this model will take time, training, and policy support—but Burris and her team are hopeful. Integrating maternal care into NICUs isn't just about convenience; it's about survival, dignity, and supporting mothers as whole people, not just caregivers. 'Her baby was in the NICU—but no one was checking on her.' That may soon change. Sources: LDI Blog Post: 'Parents of Hospitalized Infants Often Neglect Their Own Health Care' American Journal of Obstetrics & Gynecology Maternal-Fetal Medicine, May 2025 Publication Direct quotes from Dr. Heather Burris via LDI interview, June 4, 2025
Yahoo
2 days ago
- Yahoo
Luigi Mangione's ‘manifesto' reveals reason for targeting UnitedHealthcare CEO Brian Thompson, failed plot for mass casualty event: court docs
The deranged 'manifesto' of Luigi Mangione revealed the image-obsessed accused killer chose to 'wack the CEO' of UnitedHealthcare during an investor conference in New York City to generate 'headlines' — and had previously planned a bombing 'catastrophe,' court documents revealed. Parts of Mangione's scrawlings in red-spiral notebooks were revealed as part of a filing from Manhattan District Attorney Alvin Bragg Wednesday, giving insight into the thought process of the 27-year-old who allegedly targeted Brian Thompson, 50, on Dec. 4, 2024, to prove a political point about the health insurance industry which he wrote 'extracts human life force for money.' 'So say you want to rebel against the deadly, greed fueled health insurance cartel. Do you bomb the HQ? No. Bombs=terrorism,' Mangione wrote in the notebook, which he had in his backpack when he was arrested five days after he allegedly shot the exec in the back on a Midtown street. Instead, one should 'wack [sic] the CEO at the annual parasitic bean-counter convention. It's targeted and precise and doesn't risk innocents,' Mangione reasoned on Oct. 22, just six weeks before the cold-blooded slaying. Elsewhere in the manifesto, Mangione wrote that UnitedHealthcare and other insurance providers were justifiable targets because the company 'literally extracts human life force for money.' The mad screeds further revealed that the University of Pennsylvania graduate had apparently planned a mass-casualty event that could have included a bomb — expressing relief that he had not followed through on the atrocity. 'I'm glad — in a way — that I've procrastinated because it allowed me to learn more about UHC.' 'In MD would've been an unjustified catastrophe that would be perceived mostly as sick, but more importantly unhelpful,' Magione wrote of a potential attack in his native Maryland. It is not clear what exactly Mangione had planned, but he insinuated that 'innocents' would have been killed. The reason the 'model prisoner' of his Brooklyn lockup targeted Thompson was 'self-evident,' he wrote. 'The point is made in the news headline Insurance CEO killed at annual investors conference,' Mangione wrote. 'It conveys a greedy bastard that had it coming. 'Members of the public can focus on greed, on the event through reasonable acceptable discussion,' he said of the public reception the apparently planned murder would receive. Mangione was preoccupied with having action be morally palatable and understood by 'normies' — expressing repeated concern for the public response the murder would receive, even going so far as to analyze potential financial fallout for UnitedHealthcare. 'Finally, the hit is a real low blow to the company financials. All those analysts and institutional investors who came to be wooed by insurance execs? That opportunity is snuffed in an instant,' the accused assassin wrote. In the same batch of writings, Mangione leveled both praise and criticism on the Unabomber Ted Kaczynski, whom he believed failed to properly communicate his politics to 'normies.' 'For example, Ted K makes some good points on the future of humanity, but to make his point he indiscriminately mailbombs innocents. Normies categorize him as an insane serial killer, focus on the act/atrocities themselves, and dismiss his ideas,' Magione wrote. Wednesday's filing also included the note Mangione had on his person when he was arrested by police officers in Altoona, Pennsylvania just days after the vicious slaying. 'To the Feds, I'll keep this short because I do respect what you do for our country. To save you a lengthy investigation, I state plainly I wasn't working with anyone. This was fairly trivial, some elementary social engineering, basic [Computer Aided Design], and a lot of patience,' Magione wrote. 'The spiral notebook, if present, has some straggling notes and TODO lists that illuminate the gist of it,' he wrote. 'I do apologize for any strife or trauma, but it had to be done. Frankly, these parasites simply had it coming.' The note further blathered about the state of health care in the United States and the industry's capitalistic motivations. Prosecutors argue that these mad, narcissistic ramblings stand up their claim that Mangione's murder was an act of terrorism. 'The shooting itself speaks volumes of the defendant's intent. Defendant chose to shoot the CEO of the United States' largest health insurance company in front of the hotel where the company was about to conduct its annual investor conference,' Bragg wrote in the filing. Mangione's goal in assassinating Thompson was 'to send a message' which was underscored by the messages the accused allegedly left on the bullet casings ,'Deny,' 'Depose,' and 'Delay,' in reference to the book 'An American Sickness,' prosecutors alleged in the filing. 'If ever there were an open and shut case pointing to a defendant's guilt, this case is that case. Simply put, one would be hard pressed to find a case with such overwhelming evidence of guilty as to the identity of the murderer and the premeditated nature of the assassination,' prosecutors wrote in Wednesday's filing. Lawyers for Mangione filed to have the writings, found in Mangione's backpack when the then fugitive was picked up in a Pennsylvania McDonald's, excluded from the court record on grounds that he was not afforded his constitutional rights at the time of his arrest. Prosecutors agreed to hold pre-trial hearings on the admissibility of evidence, including the red spiral notebook and statements he made to police officers at the time of the arrest, the filing stated.
Medscape
3 days ago
- Medscape
Patients With HS, Obesity Report Improvements With GLP-1 RAs
In a survey of 22 patients with hidradenitis suppurativa (HS), more than two thirds reported symptom improvement after treatment with glucagon-like peptide 1 receptor agonists (GLP-1 RAs). METHODOLOGY: Researchers conducted a cross-sectional survey of 22 adults (average age, 45 years; 90.9% women) with HS who were treated with GLP-1 RAs at the University of Pennsylvania's Dermatology Department between January 2019 and August 2024. Most participants were non-Hispanic (90.9%), 54.5% were Black, and 36.4% were White; 89.5% were classified as overweight or having obesity. GLP-1 RAs prescriptions were semaglutide (40.9%), tirzepatide (36.4%), dulaglutide (18.2%), or liraglutide (4.5%), with an average treatment duration of 17 months (range, 2-108 months). Primary outcomes were HS severity and quality of life. TAKEAWAY: Most participants (77.3%) achieved weight loss averaging 31 lb; 68.2% reported improvement in HS-specific health, while 31.8% reported no change in their condition. Patient-reported symptom improvements included reduced flares (61.9%), new lesions (66.7%), pain (52.4%), drainage (61.9%), itch (47.6%), and odor (42.9%). Common side effects included gastrointestinal symptoms, allergic reactions, headaches, menstrual spotting, and appetite suppression. Nearly 60% of patients reported that HS had less impact on their daily activities, with the same percentage stating they would recommend GLP-1 RAs to other patients. IN PRACTICE: 'These data suggest GLP-1 RAs may play an important adjunctive role in the treatment of HS, particularly given the high prevalence of obesity and diabetes in the HS population,' the study authors wrote. 'Randomized controlled studies with robust patient and dermatologist-reported endpoints,' they added, 'are needed to confirm these findings and establish clinical guidelines for use of GLP-1 RAs' in HS. SOURCE: The study was led by Radhika Gupta, BA, University of Pennsylvania, Philadelphia. It was published online on May 29 in JAAD International . LIMITATIONS: Study limitations included small size, lack of clinician assessment, high nonresponse rate, and potential recall bias. DISCLOSURES: The study received funding through a philanthropic gift for HS research. Gupta disclosed being a consultant for Cabaletta Bio. One author reported receiving research funding from Amgen, Boehringer Ingelheim, Cabaletta Bio, and InflaRx. Another author reported being a consultant for Sonoma Biotherapeutics, and the fourth author reported being a consultant for Vertex Pharmaceuticals.
